Area of research
Pathology and Forensic Medicine · Cancer Research
Research interest
Research interests include Medicine, Multiple sclerosis, Placebo, Expanded Disability Status Scale, Clinical endpoint, and Phase (matter).
Safety and efficacy of MD1003 (high-dose biotin) in patients with progressive multiple sclerosis (SPI2): a randomised, double-blind, placebo-controlled, phase 3 trial
Exosomes Derived from Human Primed Mesenchymal Stem Cells Induce Mitosis and Potentiate Growth Factor Secretion
Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study
Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis